{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-099529","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.267908+00:00","generated_at":"2026-05-17T03:34:49.740637+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"InMed appoints John Bathery to board; director Baldasare to depart at AGM","bullets":["John Bathery appointed to Board effective Oct 14, 2025; Board expands to six members.","Bathery has 30+ years pharma experience, currently Head of Global BD at Takeda, led deals exceeding $60B.","Bryan Baldasare will not stand for re-election at 2025 AGM due to increasing professional obligations; no disagreements.","Bathery's expertise expected to support INM-901 (Alzheimer's) and INM-089 (AMD) programs toward clinical readiness and partnerships.","Bathery receives standard non-employee director compensation: $50,000 annual retainer, potential committee fees."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-099529","json":"https://secwatch.observer/filing/0001213900-25-099529.json","markdown":"https://secwatch.observer/filing/0001213900-25-099529.md","text":"https://secwatch.observer/filing/0001213900-25-099529.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025099529/0001213900-25-099529-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025099529/ea0261537-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:34:49.740637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}